about
The complex puzzle underlying the pathophysiology of acute coronary syndromes: from molecular basis to clinical manifestations.Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis.Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-I(Milano)Platelet biology and receptor pathways.Role of Tissue Factor in the Coagulation Network.High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need.Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type).Synergistic effect of liver X receptor activation and simvastatin on plaque regression and stabilization: an magnetic resonance imaging study in a model of advanced atherosclerosis.Safe and sustained overexpression of functional apolipoprotein A-I/high-density lipoprotein in apolipoprotein A-I-null mice by muscular adeno-associated viral serotype 8 vector gene transfer.A Fatal Case of Endocarditis on CoreValve ReValving System Caused by Enterococcus faecium Complicated by Iatrogenic Pancytopenia and Subacute Disseminated Intravascular Coagulation.Reactive oxygen species induce a procoagulant state in endothelial cells by inhibiting tissue factor pathway inhibitor.The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusionRecombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and decreases leaflet inflammation in an experimental rabbit model.C-reactive protein induces expression of matrix metalloproteinase-9: a possible link between inflammation and plaque rupture.Adeno-associated virus serotype 8 ApoA-I gene transfer reduces progression of atherosclerosis in ApoE-KO mice: comparison of intramuscular and intravenous administration.C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation.Activating stimuli induce platelet microRNA modulation and proteome reorganisation.Local cytokine production in patients with Acute Coronary Syndromes: a look into the eye of the perfect (cytokine) storm.Lipid Target in Very High-Risk Cardiovascular Patients: Lesson from PCSK9 Monoclonal Antibodies.Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: limitations of a commercial assay.Quantification of serial changes in plaque burden using multi-detector computed tomography in experimental atherosclerosis.Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation.The adipokine apelin-13 induces expression of prothrombotic tissue factor.C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes.Contrast-Enhanced Ultrasound Imaging Detects Intraplaque Neovascularization in an Experimental Model of AtherosclerosisEarly Metoprolol Administration Before Coronary Reperfusion Results in Increased Myocardial SalvageAcute ApoA-I Milano administration induces plaque regression and stabilisation in the long termCarvedilol administration in acute myocardial infarction results in stronger inhibition of early markers of left ventricular remodeling than metoprololPatients With Acute Coronary Syndrome Show Oligoclonal T-Cell Recruitment Within Unstable PlaqueTranscoronary Th-17 lymphocytes and acute coronary syndromes: new evidence from the crime scene?Cognitive Function and Atrial Fibrillation: From the Strength of Relationship to the Dark Side of Prevention. Is There a Contribution from Sinus Rhythm Restoration and Maintenance?
P50
Q33354913-CAD5DDD4-7862-49C2-B404-D5CC0A054FD4Q34761842-ED2ED90B-31A8-4F47-88CB-877B3E3C258EQ35893272-4EB8ECE4-5FAC-4379-9648-CC1EC380BB80Q38073155-E1022B5D-1B63-4104-ABE4-79E328E30FEAQ38593278-81E4C1C2-BD40-410A-81F6-23C3A6CEC00FQ38624772-855F67D8-063A-4A4E-837E-47EB72E80965Q39452210-C555A19D-82FD-4145-B733-DC4A2925CE47Q39747243-E2B10B7E-86EF-4D77-A914-7A93566DB4C1Q39809386-505A4B63-3168-40DB-94D6-E2E40FC36EC8Q41104844-A9F441EF-DC1B-4EE1-9784-23244D57C8E4Q41355131-434B65A3-88C9-49BC-B135-DDD4FFCAD035Q42559928-4D802F36-73D6-4B5C-ADA9-539DD27B343AQ43122856-DEC855E1-F54B-499D-96B0-EAA4961A9CE4Q43739933-D7C020D5-FA5A-4038-BF05-EB75FAC2EFBAQ45370445-B7FC3899-CA03-4942-B781-42B61791D3F1Q46603281-79456DEA-2E70-4046-BD10-6E0E8F2597D5Q51637678-93713333-68C2-40E1-A33B-225EEDB105F1Q51706622-9B2DF158-B9C6-4933-BE72-E7D819C57B80Q51737068-C43101F7-4827-415A-BA75-22C05FB8E049Q51818616-0C87456F-C04A-4D42-922E-7A4F38FE0BE9Q53038033-93DE3F51-03AC-4D8D-8B9D-0D1AD4214972Q53292318-86EEE080-5C51-4781-979D-880287199F18Q54189187-892855E3-CE64-43C0-BC10-2296DA7D48C4Q54357051-2BE68C7B-07B0-4861-A87F-57D016F4DE72Q56986480-72BAFB8E-E4CC-44AD-86D1-61469EBBD41EQ56986728-7B7E6574-7FF0-432A-A096-5D17B1CBDB5EQ57761286-74A1B265-2EB8-4E43-B1D2-1F9EFCD76C48Q57761333-044F7676-913C-4E36-BA83-5B150D32BA23Q61848544-7949FE8E-87BB-44CE-BE43-1F945083A660Q85090062-80EE787C-4D3B-4642-BA38-E000843FFAE5Q90194122-504C599C-7650-4B9C-BC5C-EE488564C624
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giovanni Cimmino
@ast
Giovanni Cimmino
@en
Giovanni Cimmino
@es
Giovanni Cimmino
@nl
Giovanni Cimmino
@sl
type
label
Giovanni Cimmino
@ast
Giovanni Cimmino
@en
Giovanni Cimmino
@es
Giovanni Cimmino
@nl
Giovanni Cimmino
@sl
prefLabel
Giovanni Cimmino
@ast
Giovanni Cimmino
@en
Giovanni Cimmino
@es
Giovanni Cimmino
@nl
Giovanni Cimmino
@sl
P106
P1153
6603005938
P21
P31
P496
0000-0002-3802-7052